Correction of myelotoxicity after switch of linezolid to tedizolid for prolonged treatments.

Khatchatourian, L; Le Bourgeois, A; Asseray, N; Biron, C; Lefebvre, M; Navas, D; Grégoire, M; Gaborit, B; Raffi, F; Boutoille, D

Khatchatourian, L; Le Bourgeois, A; Asseray, N; Biron, C; Lefebvre, M; Navas, D; Grégoire, M; Gaborit, B; Raffi, F; Boutoille, D.

Afiliação

Khatchatourian L; Infectious Diseases Department, University Hospital of Nantes, Nantes, France.
Le Bourgeois A; Clinical Haematology Department, University Hospital of Nantes, Nantes, France.
Asseray N; Infectious Diseases Department, University Hospital of Nantes, Nantes, France.
Biron C; Infectious Diseases Department, University Hospital of Nantes, Nantes, France.
Lefebvre M; Infectious Diseases Department, University Hospital of Nantes, Nantes, France.
Navas D; Clinical Pharmacology Department, University Hospital of Nantes, Nantes, France.
Grégoire M; Pharmacy, University Hospital of Nantes, Nantes, France.
Gaborit B; Infectious Diseases Department, University Hospital of Nantes, Nantes, France.
Raffi F; Infectious Diseases Department, University Hospital of Nantes, Nantes, France.
Boutoille D; Infectious Diseases Department, University Hospital of Nantes, Nantes, France.

J Antimicrob Chemother ; 72(7): 2135-2136, 2017 07 01.

Article em En | MEDLINE | ID: mdl-28369418

Assuntos

Antibacterianos; Linezolida; Oxazóis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linezolida / Antibacterianos Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google